CoChat

Adrenomedullin signaling is necessary for murine lymphatic vascular development

Open access
Fritz-Six, Kimberly L., Dunworth, William P., Li, Manyu, Caron, Kathleen M. · 2008 · Journal of Clinical Investigation

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

The lymphatic vascular system mediates fluid homeostasis, immune defense, and tumor metastasis. Only a handful of genes are known to affect the development of the lymphatic vasculature, and even fewer represent therapeutic targets for lymphatic diseases. Adrenomedullin (AM) is a multifunctional peptide vasodilator that transduces its effects through the calcitonin receptor-like receptor (calcrl) when the receptor is associated with a receptor activity-modifying protein (RAMP2). Here we report on the involvement of these genes in lymphangiogenesis. AM-, calcrl-, or RAMP2-null mice died mid-gestation after development of interstitial lymphedema. This conserved phenotype provided in vivo evidence that these components were required for AM signaling during embryogenesis. A conditional knockout line with loss of calcrl in endothelial cells confirmed an essential role for AM signaling in vascular development. Loss of AM signaling resulted in abnormal jugular lymphatic vessels due to reduction in lymphatic endothelial cell proliferation. Furthermore, AM caused enhanced activation of ERK signaling in human lymphatic versus blood endothelial cells, likely due to induction of CALCRL gene expression by the lymphatic transcriptional regulator Prox1. Collectively, our studies identify a class of genes involved in lymphangiogenesis that represent a pharmacologically tractable system for the treatment of lymphedema or inhibition of tumor metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci33302

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. Kato, 1997, Endocrinology., 138, 2615, 10.1210/endo.138.6.5197 · doi:10.1210/endo.138.6.5197 · Paper page
  2. Doods, 2001, Curr. Opin. Investig. Drugs., 2, 1261
  3. Del Pup, 2003, Int J Mol Med, 11, 157

Cited by

See all 261

Metadata

Authors
Fritz-Six, K. L., Dunworth, W. P., Li, M., & Caron, K. M.
Affiliations
University of North Carolina at Chapel Hill (US)
Venue
Journal of Clinical Investigation
Published
2008-01-02
Volume
118
Issue
1
Pages
40-50
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2013443224
Cited by
261
References
59
Citations by year
2026: 6 · 2025: 5 · 2024: 15 · 2023: 11 · 2022: 22 · 2021: 12 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 11 · 2016: 9 · 2015: 7 · 2014: 19 · 2013: 20 · 2012: 17
FWCI
8.82
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • Burroughs Wellcome Fund
  • American Heart Association
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 046970, R01HD046970)
Topics
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Vascular Malformations and Hemangiomas
Keywords
adrenomedullin, lymphangiogenesis, calcitonin receptor-like receptor, RAMP2, embryonic lethality, lymphatic endothelial cell proliferation, ERK signaling, Prox1, lymphatic vessels, metastasis, lymphedema treatment
MeSH terms
Prospero-Related Homeobox 1 Protein, Animals, Female, Homeostasis, Lymphatic Diseases, Lymphedema, Male, Membrane Proteins, Neoplasm Metastasis, Neoplasms, Pregnancy, Receptors, Calcitonin, Homeodomain Proteins, Neovascularization, Physiologic, MAP Kinase Signaling System, Embryo Loss, Tumor Suppressor Proteins, Lymphatic Vessels, Endothelial Cells, Embryonic Development, Intracellular Signaling Peptides and Proteins, Cell Proliferation, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 2, Calcitonin Receptor-Like Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.